Top

Published in:

01-03-2020 | Exercise Therapy | IM - COMMENTARY

Management of peripheral arterial disease in the modern era: an internist “Cup of Tea”

Author: Marco Proietti

Published in: Internal and Emergency Medicine | Issue 2/2020

Excerpt

Peripheral arterial disease (PAD), intended as the atherosclerotic occlusive disease of the lower extremities, represents a relevant vascular condition which has been estimated to affect more than 200 million people worldwide [1]. Epidemiological data showed how prevalence and incidence sharply increase with age, affecting a substantial proportion of elderly and very elderly subjects (> 20% in subjects > 80 years old), both referring to symptomatic and asymptomatic clinical presentation [1]. …

Criqui MH, Aboyans V (2015) Epidemiology of peripheral artery disease. Circ Res 116:1509–1526. https://doi.org/10.1161/CIRCRESAHA.116.303849 CrossRefPubMed

Aboyans V, Ricco J-B, Bartelink M-LEL et al (2018) 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J 39:763–816. https://doi.org/10.1093/eurheartj/ehx095 CrossRefPubMed

Parmenter BJ, Dieberg G, Smart NA (2015) Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sport Med 45:231–244. https://doi.org/10.1007/s40279-014-0261-z CrossRef

Parmenter BJ, Dieberg G, Phipps G, Smart NA (2015) Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis. Vasc Med 20:30–40. https://doi.org/10.1177/1358863X14559092 CrossRefPubMed

Hageman D, Fokkenrood HJ, Gommans LN et al (2018) Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication. Cochrane Database Syst Rev 4:CD005263. https://doi.org/10.1002/14651858.CD005263.pub4 CrossRefPubMed

Lamberti N, López-Soto PJ, Guerzoni F et al (2019) Changes in exercise capacity and risk of all-cause mortality in patients with peripheral artery disease: a 10-year retrospective cohort study. Intern Emerg Med. https://doi.org/10.1007/s11739-019-02176-3 CrossRefPubMed

Raparelli V, Pastori D, Pignataro SF et al (2018) Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study. Intern Emerg Med. https://doi.org/10.1007/s11739-018-1835-9 CrossRefPubMed

Eikelboom JW, Connolly SJ, Bosch J et al (2017) Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 377:1319–1330. https://doi.org/10.1056/NEJMoa1709118 CrossRefPubMed

Borges WR, de Carvalho ATY, Junior RA (2017) Predictors of major amputation. Intern Emerg Med 12:1079–1080. https://doi.org/10.1007/s11739-017-1652-6 CrossRefPubMed

10.

Anand SS, Caron F, Eikelboom JW et al (2018) Major adverse limb events and mortality in patients with peripheral artery disease: The COMPASS Trial. J Am Coll Cardiol 71:2306–2315. https://doi.org/10.1016/j.jacc.2018.03.008 CrossRefPubMed

11.

Huang B-T, Peng Y, Huang F-Y et al (2017) Trends in prescribing rate of statins at discharge and modifiable factors in patients with atherosclerotic cardiovascular disease. Intern Emerg Med 12:1121–1129. https://doi.org/10.1007/s11739-017-1694-9 CrossRefPubMed

12.

Kramer MHH, Bauer W, Dicker D et al (2014) The changing face of internal medicine: patient centred care. Eur J Intern Med 25:125–127. https://doi.org/10.1016/j.ejim.2013.11.013 CrossRefPubMed

Title: Management of peripheral arterial disease in the modern era: an internist “Cup of Tea”
Author: Marco Proietti
Publication date: 01-03-2020
Publisher: Springer International Publishing
Keywords: Exercise Therapy
Exercise Therapy
Peripheral Arterial Disease
Peripheral Arterial Disease
Published in: Internal and Emergency Medicine / Issue 2/2020
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-019-02236-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2020

Two different techniques of ultrasound-guided peripheral venous catheter placement versus the traditional approach in the pre-hospital emergency setting: a randomized study

Sex-related differences in prevalence, treatment and outcomes in patients with atrial fibrillation

The dangerous consequences of orthostatic hypotension

High-dose lormetazepam dependence: strange case of Dr. Jekyll and Mr. Hyde—comment

Female sex and stroke in atrial fibrillation: an intriguing relationship

Cost-effectiveness analysis of different hypertension management strategies in a community setting

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials